Megestrol Acetate

醋酸甲地孕酮

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameMegestrol Acetate
Drug Alias Name乙酸甲地孕酮megestrolum甲地孕酮醋酸酯megestrol醋甲地孕酮 +[15] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionProgesterone receptor agonists
TargetsProgesterone receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingSolid tumoursFeeding and Eating Disorders +[25] 
Global Approved IndicationsAnorexiaCachexiaWeight Loss +[5] 
Approved Indications in ChinaEndometrial NeoplasmsBreast Neoplasms
Original Approved Country/TerritoryUnited States
Original Approved Date1971/08/18
Country/TerritoryCanadaUnited StatesTaiwan +[9] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesThe Second Xiangya Hospital Of Central South UniversityThe First Affiliated Hospital With Nanjing Medical UniversityGuangzhou Institute Of Respiratory Health +[8] 
Inactive CompaniesChengdu University Of TcmBristol Myers Squibb SrlcompanyEndo Operations Ltd +[14] 
Active IndicationsChemotherapy-induced nausea and vomitingFeeding and Eating DisordersAnorexia +[13] 
Inactive IndicationsSolid tumoursHot FlashesFatigue +[12] 

Other Information

ATC CodeG03AC05G03DB02L02AB01
Related LinksWikipediaDrugBankKEGG